Inhibrx Biosciences Statistics
Total Valuation
INBX has a market cap or net worth of $181.82 million. The enterprise value is -$12.68 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | May 30, 2024 |
Share Statistics
INBX has 14.48 million shares outstanding.
| Current Share Class | 14.48M |
| Shares Outstanding | 14.48M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +4.46% |
| Owned by Insiders (%) | 19.64% |
| Owned by Institutions (%) | 49.27% |
| Float | 7.62M |
Valuation Ratios
The trailing PE ratio is 0.11.
| PE Ratio | 0.11 |
| Forward PE | n/a |
| PS Ratio | 115.96 |
| Forward PS | n/a |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.70, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.70 |
| Quick Ratio | 4.48 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -169.97% |
| Revenue Per Employee | $9,116 |
| Profits Per Employee | $10.05M |
| Employee Count | 172 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.88 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 13.87 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.38 |
| Average Volume (20 Days) | 88,760 |
Short Selling Information
The latest short interest is 1.22 million, so 8.43% of the outstanding shares have been sold short.
| Short Interest | 1.22M |
| Short Previous Month | 1.29M |
| Short % of Shares Out | 8.43% |
| Short % of Float | 16.02% |
| Short Ratio (days to cover) | 12.51 |
Income Statement
In the last 12 months, INBX had revenue of $1.57 million and earned $1.73 billion in profits. Earnings per share was $119.38.
| Revenue | 1.57M |
| Gross Profit | -189.39M |
| Operating Income | -303.34M |
| Pretax Income | n/a |
| Net Income | 1.73B |
| EBITDA | -301.44M |
| EBIT | -303.34M |
| Earnings Per Share (EPS) | $119.38 |
Full Income StatementBalance Sheet
The company has $196.33 million in cash and $1.84 million in debt, giving a net cash position of $194.50 million or $13.44 per share.
| Cash & Cash Equivalents | 196.33M |
| Total Debt | 1.84M |
| Net Cash | 194.50M |
| Net Cash Per Share | $13.44 |
| Equity (Book Value) | 178.47M |
| Book Value Per Share | 12.33 |
| Working Capital | 163.35M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$143.21 million and capital expenditures -$6.02 million, giving a free cash flow of -$149.23 million.
| Operating Cash Flow | -143.21M |
| Capital Expenditures | -6.02M |
| Free Cash Flow | -149.23M |
| FCF Per Share | -$10.31 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -19,345.34% |
| Pretax Margin | 110,218.62% |
| Profit Margin | 110,218.75% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |